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Abstract We explored whether the M2 muscarinic receptor
in the guinea pig ileum elicits a highly potent, direct-
contractile response, like that from the M3 muscarinic
receptor knockout mouse. First, we characterized the
irreversible receptor-blocking activity of 4-DAMP mustard
in ileum from muscarinic receptor knockout mice to verify
its M3 selectivity. Then, we used 4-DAMP mustard to
inactivate M3 responses in the guinea pig ileum to attempt
to reveal direct, M2 receptor-mediated contractions. The
muscarinic agonist, oxotremorine-M, elicited potent con-
tractions in ileum from wild-type, M2 receptor knockout,
and M3 receptor knockout mice characterized by negative
log EC50 (pEC50) values ± SEM of 6.75±0.03, 6.26±0.05,
and 6.99±0.08, respectively. The corresponding Emax
values in wild-type and M2 receptor knockout mice were
approximately the same, but that in the M3 receptor
knockout mouse was only 36% of wild type. Following
4-DAMP mustard treatment, the concentration–response
curve of oxotremorine-M in wild-type ileum resembled that
of the M3 knockout mouse in terms of its pEC50, Emax, and
inhibition by selective muscarinic antagonists. Thus,
4-DAMP mustard treatment appears to inactivate M3
responses selectively and renders the muscarinic contractile
behavior of the wild-type ileum similar to that of the M3
knockout mouse. Following 4-DAMP mustard treatment,
the contractile response of the guinea pig ileum to
oxotremorine-M exhibited low potency and a competitive-
antagonism profile consistent with an M3 response. The
guinea pig ileum, therefore, lacks a direct, highly potent,
M2-contractile component but may have a direct, lower
potency M2 component.
Keywords Ileum.Guineapig.Muscarinicreceptor
knockoutmice.4-DAMPmustard.M2 muscarinic receptor.
M3 muscarinic receptor
Introduction
Subtype selective antagonists inhibit muscarinic contrac-
tions of gastrointestinal and urinary bladder smooth
muscle in a manner that agrees with an M3 receptor
mechanism (Eglen et al. 1996). This behavior is consistent
with the known coupling of the M3 receptor to Gq/11
(Noronha-Blob et al. 1989; Candell et al. 1990;R o f f e le t
al. 1990), which is often involved in Ca
2+ mobilization.
The details of how M3-Gq/11 signaling leads to contraction
are unclear, however, because contraction of the guinea
pig ileum depends mainly on an extracellular source of
Ca
2+ (Bolger et al. 1983).
The M2 muscarinic receptor is also expressed in smooth
muscle, and it outnumbers the M3 by a factor of at least
four (Eglen et al. 1996). The apparent lack of a role of the
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of its known signaling mechanisms in smooth muscle (see
Table 1). Stimulation of the M2 receptor activates a
nonselective cation conductance; however, the conductance
depends on Ca
2+ (Bolton 1979; Inoue 1991; Sakamoto et
al. 2007). This explains why there is little increase in
conductance unless both the M2 and the Ca
2+-mobilizing
M3 receptor are activated simultaneously. The M2 receptor
is also known to inhibit Ca
2+-activated K
+ channels, which
release smooth muscle from inhibitory K
+ currents and
enhance contraction (Kotlikoff et al. 1992). Like the cation
conductance, however, this mechanism also requires Ca
2+
mobilization by another receptor to activate the K
+ current
before the M2 receptor can inhibit it. Finally, the M2
receptor inhibits adenylate cyclase in smooth muscle. This
inhibition opposes the relaxant effect of receptors that
increase cyclic adenosine monophosphate (cAMP; e.g.,
β-adrenoceptor; Thomas et al. 1993; Thomas and Ehlert
1996; Sawyer and Ehlert 1998; Ehlert et al. 2005), and this
effect requires Ca
2+ mobilization in the first place;
otherwise, there is no contraction to be relaxed by the
β-adrenoceptor and no β-adrenoceptor response for the M2
receptor to inhibit. In trachea, M2 receptor activation
opposes forskolin- but not isoproterenol-induced relaxation,
which is consistent with the postulate that the β2-adreno-
ceptor mediates relaxation through a non-cAMP mecha-
nism in the trachea (Ostrom and Ehlert 1998; 1999).
It may seem that these M2 effects would be manifest in
standard pharmacological antagonism studies. However, we
have shown that the competitive antagonism of a response
mediated through M2–M3 receptor interactions resembles
the profile of the directly acting receptor (i.e., the M3) and
not that of the conditionally acting receptor (i.e., the M2;
Ehlert 2003). Thus, the M3 antagonism profile of standard
muscarinic contractions of the ileum and bladder is not
inconsistent with the postulate that both M2 and M3
receptors interact to elicit contraction.
Studies on the mouse uterus are consistent with a
conditional role for the M2 receptor in contraction
(Kitazawa et al. 2008). The competitive antagonism of
the muscarinic contractile response of wild-type uterus
resembles an M3 profile, but the Emax for contraction is
i n h i b i t e db ya b o u t5 0 %i nu t e r u sf r o mt h eM 2 knockout
(KO) mouse. In the M3 KO mouse, muscarinic contrac-
tions are absent. Thus, the M2 receptor is unable to elicit
direct contraction of the mouse uterus, but is able to
enhance M3 receptor-mediated contractions.
Following inactivation of M3 receptors in guinea pig
ileum and colon, we have identified two types of
muscarinic contractile responses for the M2 receptor. One
is a highly potent M2 receptor-mediated inhibition of
forskolin- and β-adrenoceptor-mediated relaxation, and
the other is a less potent M2 receptor-mediated enhance-
ment of M3 receptor contractile signaling (Ehlert 2003).
Circumstantial evidence suggests that the latter is involved
in heterologous desensitization, which requires activation of
both M2 and M3 receptors and is potently antagonized by
M2 selective antagonists (Griffin et al. 2004).
Studies on muscarinic receptor knockout mice are
consistent with these observations but have revealed an
additional, highly potent, direct-contractile mechanism for
the M2 receptor. In M3 KO mice, the M2 receptor elicits a
highly potent contractile response in ileum and trachea,
although the maximum of this response is only about 40%
that of the muscarinic contraction in wild-type and M2 KO
tissue (Matsui et al. 2000; Matsui et al. 2002).
Table 1 Summary of the types of contractions elicited by M2 and M3 muscarinic receptors in smooth muscle and their putative mechanisms
Receptor Type of contraction Tissue and species Putative mechanism
M2 Direct contraction Mouse: ileum, trachea, and
urinary bladder
Unknown, Gi mobilization of extracellular Ca
2+
Conditional inhibition of cAMP-
mediatied relaxation
Mouse: ileum, trachea, and
urinary bladder
Gi-mediated inhibition of adenylate cyclase
Guinea pig: ileum, trachea, colon,
and esophagus
Conditional enhancement of M3-
receptor-mediated contraction
Mouse: ileum, urinary bladder,
and uterus
Gi stimulation of Icat;G i inhibition of BKCa
Guinea pig: colon and ileum
M3 Direct contraction Widespread in guinea pig and
mouse smooth muscle
Major: unknown Gq-mediated influx
of extracellular Ca
2+
Minor: Gq-mediated phosphoinositide hydrolysis
and release of intracellular Ca
2+
Contraction is defined as direct if activation of the indicated receptor by itself is sufficient to cause contraction. If activation of the receptor
subtype by itself has no effect on contraction but elicits or enhances contraction when other receptors are activated, then the muscarinic
contraction is defined as conditional. Further details are described in the text.
Icat nonselective cation conductance, BKCa Ca
2+-activated potassium channel
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similar, highly potent, direct-M2-receptor-mediated contrac-
tion occurs in the guinea pig ileum. We show that treatment
of the wild-type mouse ileum with 4-DAMP mustard (N-2-
chloroethyl-4-piperidinyl diphenylacetate) uncovers a highly
potent, direct-M2-contractile mechanism and converts its
pharmacological behavior into that of the M3 KO mouse. In
contrast, treatment of the guinea pig ileum with 4-DAMP
mustard caused a large, 56-fold reduction in agonist potency,
and the residual muscarinic response exhibited an M3-
pharmacological profile. Thus, the guinea pig ileum appears
to lack the highly potent direct-contractile-M2 mechanism
observed in the mouse. Our data also illustrate that ileal
smooth muscle from whole-body M3 KO mice accurately
displays the contractile activity of the M2 receptor in wild-
type mice and that 4-DAMP mustard is a useful tool for
inactivating the M3 responses selectively.
Methods
Animals M2 muscarinic receptor knockout (M2−/−;M 2 KO)
and M3 muscarinic receptor knockout (M3−/−;M 3 KO) mice
were generated as described by Matsui et al. (2002).
Contractile assays in isolated ileal tissue Contractile
measurements were made on ileum from male Hartley
guinea pigs (300–400 g) and C57Bl-6 mice (25–30 g) as
described previously (Griffin et al. 2004). The medium was
Krebs–Ringer bicarbonate (KRB) buffer (124 mM NaCl,
5 mM KCl, 1.3 mM MgCl2, 26 mM NaHCO3, 1.2 mM
KH2PO4, 1.8 mM CaCl2, 10 mM glucose) containing
indomethacin (1 μM) and maintained at 37°C and gassed
with O2/CO2 (19:1). Tissues were allowed to incubate for at
least an hour and were subsequently challenged with KCl
(50 mM) three times, followed by the measurement of a
cumulative concentration–response curve to oxotremorine-
M. This was done to speed up the equilibration of the
ileum, which undergoes a time-dependent increase in
contractile activity. After appropriate washing, the ileum
was incubated for another 30 min prior to the collection of
the data presented under “Results”. Contractile responses to
oxotremorine-M were measured using a cumulative tech-
nique. The Emax value of oxotremorine-M increased with an
increase in age or body weight of each strain of mouse. In
addition, the ileal contraction to KCl (50 mM) increased
with an increase in body weight but was similar in mice of
equivalent body weights across the different strains. All
contractions to oxotremorine-M, therefore, were normalized
relative to that elicited by KCl (50 mM).
4-DAMP mustard treatment A solution of 4-DAMP mus-
tard was first cyclized in 10 mM phosphate buffer, pH 7.4,
for 30 min at 37°C to allow formation of the aziridinium
ion (Thomas et al. 1992). The solution was placed on ice
and used as soon as possible. Ilea were incubated with 4-
DAMP mustard (40 nM) in combination with the M2
selective antagonist AF-DX 116 (4 μM; [[2-2(diethyl-
amino)methyl]-1-piperidinyl]-acetyl]-5,11-dihydro-6H-
pyrido[2,3b][1,4] benzodiazepine-6-one) for one or two
1-h time periods, in a final volume of 50 ml of KRB buffer.
This minimum volume of medium is essential because
4-DAMP mustard is inactivated by tissue nucleophiles,
particularly in substantial tissues like the guinea-pig ileum.
After these incubations, the tissue was washed three times
and incubated for 30 min prior to contractile measurements.
Analysis of concentration–response curves Concentration–
response curves were analyzed using GraphPad Prism
software (GraphPad Software, Inc., La Jolla, CA, USA)
using the variable slope concentration–response curve
function. The negative log dissociation constants of
antagonists (pKB) were estimated from experiments in
which their ability to shift the agonist concentration–
response curve to the right was measured (Arunlakshana
and Schild 1959):
pKB ¼  Log
I ½ 
shift   1

In this equation, [I] denotes the molar concentration of
antagonist, and shift denotes EC50 value of the agonist
measured in the presence of the antagonist divided by that
measured in its absence. The Log shift and pKB values were
determined for individual experiments and averaged. The
significance of differences were evaluated using the
unpaired Student's t test with the overly conservative
Bonferroni adjustment of the critical value of P where
appropriate.
Drugs and chemicals The reagents used in this study
were obtained from the following sources: AF-DX 116,
Boehringer Ingelheim Pharmaceutical, Ridgefield, CT,
USA; oxotremorine-M and indomethacin, Sigma RBI,
Natick, MA, USA; 4-DAMP was synthesized using a
method similar to that described by Barlow et al. (1976),
and 4-DAMP mustard was synthesized as described
previously (Thomas et al. 1992).
Results
Contractile activity of oxotremorine-M in guinea pig and
mouse ileum Oxotremorine-M potently elicited contrac-
tions in ilea from both the mouse and guinea pig. The
average negative log EC50 (pEC50) ± SEM and Emax ±
Naunyn-Schmied Arch Pharmacol (2009) 380:327–335 329SEM values of oxotremorine-M were both greater in guinea
pig (7.48±0.05 and 58.2±4.5 mN) than in wild-type mouse
(6.75±0.03 and 12.2±0.5 mN). The average responses and
their associated SEM values in guinea pig and wild-type
mouse were normalized relative to the average Emax value
of its respective group (i.e., guinea pig or wild-type mouse),
and the normalized data are plotted in Fig. 1. The higher
potency of oxotremorine-M in the guinea pig is readily
apparent from the figure. The contractile activity of
oxotremorine-M was also investigated in ilea from M2
and M3 KO mice. The responses in each mouse ileum were
first normalized relative to the contraction elicited by KCl
(50 mM) as described under “Methods.” The mean
contractile responses and their respective SEM values were
then normalized relative to the Emax value of the wild-type
mouse. The average Emax value ± SEM of oxotremorine-M
in the M2 KO mouse ileum (101.2±7.5%) was similar to
that of wild type, whereas that measured in the M3 KO
mouse was substantially smaller (35.7±3.5%). Normaliza-
tion of the muscarinic responses in the mouse to that of
KCl did not significantly change the relationship among
the Emax values in the M2 KO and M3 KO strains relative
to wild type but did cause a modest reduction in the
variance of the mean estimates in wild-type and M2 KO
mice. The potency of oxotremorine-M in the M2 KO
mouse (pEC50=6.26±0.05) was about one third that of the
wild-type mouse, whereas that in the M3 KO mouse
(pEC50, 6.99±0.08) was 1.7-fold greater than wild type.
These differences in pEC50 were significant as indicated in
the summary of these data in the legend to Table 2.S i n c e
prior reports have shown that the ileum from the M2/M3
double KO mouse lacks a muscarinic contractile response,
the data in Fig. 1 are consistent with the postulate that the
muscarinic contractile response in the wild-type mouse
ileum includes a major M3-receptor component as well as
a minor, but more potent, M2-receptor component. Matsui
et al. (2000; 2002) have reached a similar conclusion .
Antagonism of the muscarinic response in mouse ileum We
investigated two muscarinic antagonists (AF-DX 116 and
4-DAMP (N,N-dimethyl-4-piperidinyl diphenylacetate))
with known selectivity for receptor subtypes to determine
if their inhibitory action in the mouse ileum is consistent
with the picture of M2 and M3 receptor function described
above in connection with our studies on KO mice. The
binding affinities (pKD, negative log dissociation constant)
of AF-DX 116 for the human M2 and M3 receptor subtypes
are 7.27±0.05 and 6.10±0.06, and those of 4-DAMP are
7.87±0.03 and 8.81±0.05, respectively (Esqueda et al.
1996; Griffin et al. 2004). Thus, AF-DX 116 exhibits about
15-fold higher affinity for the M2 receptor relative to M3,
whereas 4-DAMP exhibits an opposite tenfold selectivity.
4-DAMP actually exhibits high affinity for all subtypes of
the muscarinic receptor except the M2. We tested each
antagonist at a concentration approximately equal to the
greater of its two KD values for M2 and M3 receptors. With
this strategy, the M2 selective AF-DX 116 and the M3-
selective 4-DAMP should only cause about twofold shifts
in the concentration–response curve of an agonist for
eliciting M3 and M2 responses, respectively, but much
greater ten- to 15-fold shifts in responses mediated by the
receptors for which they exhibit selectivity (i.e., M2 and
M3, respectively).
The results of antagonism studies using AF-DX 116
(1 μM) in the mouse ileum from wild-type, M2 KO, and M3
Fig. 1 Contractile activity of oxotremorine-M in ilea from the guinea
pig and from wild type, M2 KO, and M3 KO mice. The data represent
the mean values ± SEM from experiments on 13 guinea pigs, 39 wild-
type mice, 25 M2 KO mice, and 25 M3 KO mice. The responses in the
guinea-pig ileum have been normalized relative to Emax and those in
mice to the Emax in wild type
Table 2 Contractile activity of oxotremorine-M in guinea pig ileum
and in wild-type, M2 KO, and M3 KO mouse ileum
pEC50 Emax
a (% wild type) Hill slope
Guinea pig (13) 7.48±0.05
b 100±7.7 1.38±0.20
Mouse
Wild type (39) 6.75±0.03 100±4.1 1.14±0.06
M2 KO (25) 6.26±0.05
c 101±7.5 1.18±0.06
M3 KO (25) 6.99±0.08
c 35.7±3.5
d 1.18±0.18
The data are from Table 1 and represent the mean values ± SEM. The
number of experiments is indicated in parentheses
aThe Emax and SEM values have been normalized relative to the
average wild-type Emax value for each species.
bSignificantly different from the pEC50 value of wild-type mouse
ileum (P=4.3×10
−16)
cOne-way analysis of variance showed highly significant differences
among the pEC50 values measured in wild type, M2 KO, and M3 KO
mouse ilea (F2,86=44.14; P=6.4×10
−14). Using the unpaired Student's
t test, the P values for differences among the mean pEC50 values of
wild type and M2 KO (P=3.3×10
−11), wild type and M3 KO (P=
0.0054), and M2 KO and M3 KO (P=2.1×10
−10) were all less than
Bonferroni's adjusted 0.05 value of P for three comparisons (0.0167).
dSignificantlydifferentfromtheEmax of wild-type ileum (P=6.1×10
−19)
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mouse (Fig. 2c), AF-DX 116 caused a 10.5-fold shift in the
concentration response curve of oxotremorine-M, which
yielded an estimated pKB value of (6.97±0.03) similar to its
binding affinity for the M2 receptor (pKD=7.27±0.05). In
contrast, AF-DX 116 only caused 2.6- and 2.7-fold shifts in
the concentration response curves of oxotremorine-M in
wild-type and M2 KO mice, respectively. 4-DAMP
exhibited the opposite selectivity (Fig. 2a–c). It caused a
6.8-fold shift in the concentration–response curve of
oxotremorine-M in the M2 KO mouse (Fig. 2b), which
yields an estimated pKB value (8.74±0.19) similar to its
binding affinity for the M3 receptor (8.81±0.05, Griffin et
al. 2004). A similar shift of 14-fold was observed in the
wild-type mouse (Fig. 2a), whereas a much smaller shift
(1.5-fold) was measured in ilea from the M3 KO mouse
(Fig. 2c). These results are summarized in Table 3 and are
consistent with the postulate mentioned above that the
muscarinic contractile response in the mouse ileum includes
major and minor, directly acting M3 and M2 components,
respectively.
We also investigated the effects of 4-DAMP mustard on
the muscarinic contractile response of the mouse ileum
(Fig. 3). At neutral pH, 4-DAMP mustard forms an
aziridinium ion that binds covalently to muscarinic recep-
tors. When used at a concentration of 40 nM in the presence
of AF-DX 116 (4 μM) for 1 h at 37°C, 4-DAMP mustard
inactivates 96% of human M3 receptors expressed in
CHO cells but only 22% of human M2 receptors (Griffin
et al. 2003). Isolated ilea from wild-type, M2 KO, and M3
KO mice were incubated, with 4-DAMP mustard (40 nM)
in combination with AF-DX 116 (4 μM) for a total time of
2 h, and washed extensively (see “Methods”). This
treatment reduced the Emax value of oxotremorine-M in
wild-type mouse ileum to only 43% of control while
having little effect on EC50.A ss h o w ni nF i g .3a,t h e
residual response in wild-type ileum after 4-DAMP
mustard treatment was nearly identical to that measured
in the untreated ileum from the M3 KO mouse. Similar
results were obtained when the incubation with 4-DAMP
mustard only lasted 1 h (Table 4) .T r e a t m e n tw i t h4 - D A M P
mustard (2 h) caused a large inhibition in the response to
oxotremorine-M in the M2 KO mouse ileum (Fig. 3b), but
had little effect on the response in the M3 KO ileum
(Fig. 3c). The results are consistent with the postulate that
4-DAMP mustard treatment selectively inactivates M3
responses over M2, thereby converting the muscarinic
behavior of the wild-type ileum into that of the M3 KO
ileum. These results are summarized in Table 4.
To obtain further support for this hypothesis, we
characterized the pharmacological profile of the muscarinic
response in 4-DAMP mustard-treated wild-type ileum using
the competitive antagonists, 4-DAMP and AF-DX 116.
After 4-DAMP mustard treatment, AF-DX 116 (1 μM) and
4-DAMP (10 nM) caused 9.8- and 3.0-fold shifts in the
concentration response curve to oxotremorine-M in wild-
type mouse ileum, yielding pKB estimates of 6.90±0.13 and
8.30±0.28, respectively (Fig. 3d). This profile of antago-
nism is similar to that described above for the ileum from
M3 KO mice (Fig. 2c).
Characterization of the muscarinic contractile response in
guinea pig ileum The effects of AF-DX 116 (1 μM) and 4-
DAMP (10 nM) on the contractile response to
oxotremorine-M in the guinea pig ileum are shown in
Fig. 4a. These two antagonists caused shifts of 3.1- and
tenfold, respectively, in the concentration–response curve.
This behavior is consistent with the well-known M3 profile
of this tissue, yielding pKB±SEM values of 6.28±0.10 and
9.00±0.06 for AF-DX 116 and 4-DAMP, respectively, in
Fig. 2 Competitive antagonism of the response to oxotremorine-M by
AF-DX 116 (1 μM) and 4-DAMP (10 nM) in ilea from wild type (a),
M2 KO (b), and M3 KO (c) mice. The data are normalized relative to
the Emax of control and represent the mean values ± SEM from four to
seven experiments
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M3 receptor. Treatment of the guinea pig ileum with
4-DAMP mustard (40 nM) in combination with AF-DX
116 (4 μM) for 2 h followed by washing caused a 56-fold
dextral shift in the concentration–response curve to
oxotremorine-M, with a small increase in its Emax value
(Fig. 4b). This small effect can be attributed to time, since
we observed time-dependent increases in Emax with repeti-
tive measurement of concentration–response curves to
oxotremorine-M. Unlike the behavior observed in wild-type
mouse ileum, treatment of the guinea pig ileum with
4-DAMP mustard did not uncover a direct, highly potent
contraction with a low Emax value. Following 4-DAMP
mustard treatment, the effects of AF-DX 116 (1.3-fold
dextral shift) and 4-DAMP (4.3-fold dextral shift) on the
EC50 value of oxotremorine-M in the guinea pig ileum
where qualitatively similar to those measured before
4-DAMP mustard treatment and, hence, suggestive of a
direct M3 mechanism. Control experiments showed that the
potency of oxotremorine-M increased 1.45-fold 1 h after
4-DAMP mustard treatment, suggesting that the measured
antagonist-induced shifts were underestimated. Correcting
Table 3 Effects of AF-DX 116 and 4-DAMP on the contractile response to oxotremorine-M in mouse ileum
AF-DX 116 (1μM) 4-DAMP (10nM)
Log shift
a pKB Log shift
a pKB
Wild type (7, 7) 0.42±0.06 6.17±0.14 1.16±0.13 9.12±.14
M2 KO (4, 6) 0.43±0.18 5.93±0.42 0.83±0.19 8.74±.19
M3 KO (7, 4) 1.02±0.02 6.97±0.03 0.18±0.17 n.d.
b
The data are from Fig. 1 and represent the mean values ± SEM. The two numbers in parentheses beside each mouse strain denote the number of
experiments done with AF-DX 116 and 4-DAMP, respectively
aThe Log shift denotes the logarithm of the ratio of the EC50 value measured in the presence of the antagonist divided by that measured in its
absence
bThe pKB was not determined because of the low log shift value
Fig. 3 Effects of 4-DAMP mustard treatment on contractions elicited
to oxotremorine-M in mouse ileum. a Responses were measured in
ilea from the M3 KO mouse (open triangles) and from wild-type ileum
before (open circles) and after (closed triangles) treatment with
4-DAMP mustard (40 nM) in combination with AF-DX 116 (4 μM)
for 2 h followed by washing as described under “Methods.” b
Responses were measured in ilea from the M2 KO mouse before (open
circles) and after (closed triangles) treatment with 4-DAMP mustard
as described in a. c Same as b except that responses were measured in
ilea from the M3 KO mouse. d All responses were measured in ilea
from wild-type mice that had been treated with 4-DAMP mustard as
described in a. After this treatment, responses were measured in the
absence (open circles) and presence of AF-DX 116 (1 μM; closed
triangles) or 4-DAMP (10 nM; open triangles). Mean values ± SEM
from five to seven experiments are plotted in a–d
332 Naunyn-Schmied Arch Pharmacol (2009) 380:327–335these measured shifts by a factor of 1.45 yields theoretical
shifts of 1.89 and 6.21 for AF-DX 116 (1 μM) and 4-DAMP
(10 nM), respectively, which yield pKB values of 5.94 and
8.72 for these antagonists.
Discussion
Muscarinic agonists elicit contraction in isolated ileum,
trachea, and urinary bladder from many mammals, includ-
ing the mouse. This function undergoes small, large, and
complete losses in the M2 KO, M3 KO, and M2/M3 double
KO mice, respectively (Matsui et al. 2000; Matsui et al.
2002), showing that M2 and M3 receptors account for
contraction and that, in the absence of other agents, the
latter contributes more to the response than the former.
Contractions to efficacious muscarinic agonists are insen-
sitive to tetrodotoxin, indicating that the relevant M2 and
M3 receptors are located postjunctionally (Unno et al.
2005). Muscarinic agonists display high potency for
eliciting contraction through the M2 receptor in smooth
muscle from the M3 KO mouse, yet compared to that
measured in wild-type tissue, their Emax values are only
10% in urinary bladder and 30–40% in ileum and trachea
(Matsui et al. 2000). Direct M2 receptor-mediated contrac-
tions in the ileum from the M3 KO mouse have been
reported to be evanescent (Unno et al. 2005), although we
have found them to be reasonably stable over the time
required to measure data for a cumulative, concentration–
response curve. These contractions are pertussis toxin-
sensitive and inhibited completely by the voltage-dependent
Ca
2+ antagonist, nicardipine (Unno et al. 2005). In contrast,
M3 receptor-mediated contractions are pertussis toxin-
insensitive and are partially inhibited by nicardipine in
mouse (Unno et al. 2005) but nearly completely inhibited
by voltage-sensitive Ca
2+ channel blockers in guinea pig
(Bolger et al. 1983).
The first report (Matsui et al. 2000) of a directly
mediated M2 contraction in the M3 KO mouse was
surprising because prior studies on the guinea pig had not
uncovered such a role, although clear evidence for
conditional M2 responses—that is, those dependent on
other receptors—had been observed. It might be argued that
the direct M2 effect had gone unnoticed in guinea pigs
because the antagonists used to characterize contraction
lacked the requisite selectivity for muscarinic receptor
subtypes to detect a small M2 effect. This raises the
question of whether the direct contractile role of the M2
receptor was missed in the guinea pig or whether guinea
pigs simply differ from mice in their lack of this potent M2
function. For these reasons, we investigated whether it is
possible to convert the muscarinic response of the ileum
Table 4 Effect of 4-DAMP mustard treatment (40 nM) in combina-
tion with AF-DX 116 (4 μM) on the contractile activity of
oxotremorine-M in mouse ileum
Control 4-DAMP mustard
pEC50 pEC50 Emax (%)
a
Wild type
1 h treatment (9) 6.59±0.08 6.62±0.17 34±8
2 h treatment (7) 6.96±0.06 6.89±0.14 43±9
M2 KO
2 h treatment (6) 6.39±0.09 5.80±0.16 33±9
M3 KO
2 h treatment (5) 7.15±0.08 7.36±0.09 74±3
The data are from Fig. 2 and represent the mean values ± SEM. The
numbers in parentheses beside each mouse strain denote the number
of experiments. The Emax values in 4-DAMP mustard-treated ileum
are normalized relative to that measured under control conditions
aEmax values and their SEM have been normalized relative to the
average Emax value of control
Fig. 4 Effects of AF-DX 116 (1 μM) and 4-DAMP (10 nM) before
(a) and after (b) 4-DAMP mustard treatment on contractile responses
to oxotremorine-M in the guinea pig ileum. a Responses were
measured in the absence (open symbols) and presence of AF-DX
116 (closed triangles) or 4-DAMP (open triangles). b Responses were
first measured under control conditions (open circles). After 4-DAMP
mustard treatment and washing, responses were measured in the
absence (closed triangles) and presence of AF-DX 116 (closed
diamonds)o r4 - D A M P( open triangles). Ilea were treated with
4-DAMP mustard (40 nM) for 1 h in the presence of AF-DX 116
(4 μM) and were then washed three times as described under
“Methods.” The data in a and b represent the mean response values ±
SEM from ten to 13 experiments
Naunyn-Schmied Arch Pharmacol (2009) 380:327–335 333from the wild-type mouse into that of the M3 KO using
4-DAMP mustard and, if so, whether this treatment reveals
a direct M2 receptor-mediated contraction in the guinea pig.
The compound, 4-DAMP mustard, is a nitrogen mustard
derivative that cyclizes spontaneously into a reactive aziridi-
nium ion nearly identical to the competitive muscarinic
antagonist 4-DAMP except for its lack of two hydrogen
atoms (Barlow et al. 1990). The latter compound only
exhibits about tenfold higher affinity for the M3 receptor
over the M2. At 100% receptor occupancy, 4-DAMP
mustard alkylates M2 and M3 receptors at a similar rate (rate
constant, 0.1 min
−1; half time, 7 min), but selectivity for the
M3 receptor can be achieved at the cost of a slower rate of
alkylation by using a lower concentration of the aziridinium
ion or by adding a competitive, M2-selective antagonist (e.g.,
AF-DX 116) to the incubation (Thomas et al. 1992). Using
4-DAMP mustard (40 nM) in combination with AF-DX 116
(4 μM) for 1 h, we showed that it is possible to alkylate 96%
of a population of the human M3 receptor expressed in CHO
cells, while only inactivating 22% of human M2 receptors
(Griffin et al. 2003).
Treatment of the wild-type mouse ileum with 4-DAMP
mustard reduced the Emax of the contractile response to
oxotremorine-M by about 60% while having little effect on
EC50. The residual concentration–response curve resembled
that measured in the M3 KO mouse, in terms of its EC50,
Emax, and antagonism by AF-DX 116 and 4-DAMP. These
compounds had pKB values of 6.90 and 8.30, respectively,
that differed by only about 0.4 log units from their binding
affinities (pKD) for human M2 receptors (7.27 and 7.87
(Esqueda et al. 1996; Griffin et al. 2004)). The difference
may be ascribed to recycling of muscarinic receptors after
4-DAMP mustard treatment as discussed below. In contrast,
the pKB values of the same compounds in wild-type mouse
ileum (6.17 and 9.12) are similar to their respective binding
affinities (pKD)f o rt h eM 3 receptor (6.10 and 8.81 (Esqueda
et al. 1996; Griffin et al. 2004)). The direct M2-component of
contraction in the wild-type mouse does not significantly
perturb the antagonism profile of the wild-type response
from that expected for a pure M3 response, illustrating the
inability of these antagonists to resolve a minor receptor
component of the response. 4-DAMP mustard treatment had
little effect on muscarinic contractions in the M3 KO mouse.
Our data suggest that 4-DAMP mustard treatment selectively
inactivated M3 receptors in the wild-type ileum to unmask
direct M2-receptor-mediated contractions that behaved sim-
ilarly to those of the M3 KO mouse.
In contrast, 4-DAMP mustard treatment completely elim-
inated the high-potency response of the guinea pig ileum to
oxotremorine-M. Only low-potency contractions to
oxotremorine-M remained after 4-DAMP mustard treatment,
for the concentration–response curve shifted tothe right about
56-fold with no decline in Emax. These low-potency contrac-
tions were antagonized by AF-DX 116 and 4-DAMP in a
manner qualitatively resembling that expected for an M3
response. The shift in the concentration–response curve
caused by the M2-selective AF-DX 116 was only one
fortieth of that expected for an M2 response, and that caused
by the M3-selective 4-DAMP was threefold greater than
expected for an M2 response. Both shifts, however, were
about threefold smaller than that expected for an M3
response. This decrement in antagonism may be explained,
in part, by the trafficking of new muscarinic receptors to the
plasma membrane after 4-DAMP mustard treatment because
control experiments showed about a 1.5-fold increase in the
potency of oxotremorine-M during the same time period.
The guinea pig ileum is exquisitely sensitive to musca-
rinic agonists, and only a fraction of 1% of the muscarinic
receptor population is required for the response at EC50
(Ringdahl 1984). A recovery of such a small amount of
receptors seems plausible after 4-DAMP mustard treatment
and before the response to oxotremorine-M was measured
in the presence of antagonist (45–60 min). This time was
used for washing residual agonist from the tissue and
incubating with antagonist. In tissue homogenates, there is
no recovery of muscarinic receptor binding after a few
hours following 4-DAMP mustard treatment (Thomas et al.
1992), although the error in this measurement is at the same
level as that capable of causing a small leftward shift in the
concentration–response curve (i.e., about 2% of the
receptor population).
In contrast to that of the guinea pig, the M3 response of
the mouse ileum is much less sensitive to oxotremorine-M.
Based on our prior work, it requires approximately 30%
receptor occupancy by oxotremorine-M to elicit a 50%
contractile response (Tran et al. 2009). This difference in
the sensitivities of the mouse and guinea pig ileum can
explain why it was possible to reduce the Emax value of
oxotremorine-M in both the wild-type and M2 KO ileum,
while the same treatment did not affect the Emax in the
guinea pig ileum.
Our inability to detect direct, M2-receptor-mediated con-
tractions in the guinea pig ileum does not rule them out; our
point is that if they exist, they must be mediated by
oxotremorine-M with much less potency than in the mouse
or that it requires an agonist with much greater efficacy than
oxotremorine-M to detect them. Since relative efficacy of
oxotremorine-M is similar to or greater than that of
acetylcholine at the M2 receptor (Ehlert 1985;T r a ne ta l .
2009), our data show that highly potent, direct M2-receptor-
mediated contractions are not mediated by acetylcholine
physiologically. Thus, although the M2 receptor of the
guinea pig ileum mediates a high potency inhibition of
relaxation and a low potency enhancement of M3 receptor-
mediated contractions (Ehlert 2003), it does not mediate a
high potency direct contraction like that of the mouse ileum.
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